Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by elgin1on Jan 26, 2020 1:28pm
61 Views
Post# 30600238

RE:Rb2211 - Midam (Stock Price) a historical read 10 Sep 2019+

RE:Rb2211 - Midam (Stock Price) a historical read 10 Sep 2019+
jwallisca wrote: Rb2211:

The well written, historical read via the link below has used what was available to it. However, because Sernova has issued nothing of technical value after the C-Peptide news 16 October until Witkowski leaked a headline on his website last week, any promoter of Sernova has nothing with which to promote.

The link below shows Stock Price (Midam) updated information up to and including the C-Peptide release 16 October 2019 in response to ViaCyte's hype in early October.
https://stockprice.com/stock-market-sectors/biotechnology-sector/a-breakthrough-solution-for-a-186-billion-market-biotech-investors-have-first-look-advantage-2019-09-10/

At the end, one finds a disclaimer because the article was paid for. Keep in mind that the information in the link
 is old stuff. We wait for new stuff, likely this coming week because of Witkowski's headline leak. (Tuesday, or Monday historically are Sernova's preferred days to issue news.)

Disclaimer: Pursuant to an agreement between Midam Ventures LLC and Sernova (TSX:SVA) (OTC:SEOVF), Midam has been paid $350,000 for a period from September 11, 2019 to September 22, 2020. We may buy or sell additional shares of Sernova (TSX:SVA) (OTC:SEOVF) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Sernova (TSX:SVA) (OTC:SEOVF). Click Here For Full Disclaimer.

jwall



Jwall,

How do you know there is a news release this week?  Who told you? 
Bullboard Posts